This trial is testing whether SBRT is better than conventional radiation therapy when given with chemotherapy for patients with inoperable lung cancer.
1 Primary · 0 Secondary · Reporting Duration: 8 weeks postradiation
102 Total Participants · 0 Treatment Group
Primary Treatment: Treatment · No Placebo Group · N/A
Age 18+ · All Participants · 10 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you: